70
Views
6
CrossRef citations to date
0
Altmetric
Original Research

Effects of insulin analogs and glucagon-like peptide-1 receptor agonists on proliferation and cellular energy metabolism in papillary thyroid cancer

, , , , &
Pages 5621-5631 | Published online: 24 Nov 2017

References

  • ChenWZhengRBaadePDCancer statistics in China, 2015CA Cancer J Clin201666211513226808342
  • ZhouYZhangXGuCXiaJDiabetes mellitus is associated with breast cancer: systematic review, meta-analysis, and in silico reproductionPanminerva Med201557310110825971328
  • HuxleyRAnsary-MoghaddamABerrington de GonzalezABarziFWoodwardMType-II diabetes and pancreatic cancer: a meta-analysis of 36 studiesBr J Cancer200592112076208315886696
  • GurayaSYAssociation of type 2 diabetes mellitus and the risk of colorectal cancer: a meta-analysis and systematic reviewWorld J Gastroenterol201521196026603126019469
  • FangHYaoBYanYDiabetes mellitus increases the risk of bladder cancer: an updated meta-analysis of observational studiesDiabetes Technol Ther2013151191492224180357
  • El-SeragHBHampelHJavadiFThe association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidenceClin Gastroenterol Hepatol20064336938016527702
  • JonassonJMLjungRTalbackMHaglundBGudbjornsdottirSSteineckGInsulin glargine use and short-term incidence of malignancies-a population-based follow-up study in SwedenDiabetologia20095291745175419588120
  • AdamiHOMcLaughlinJEkbomACancer risk in patients with diabetes mellitusCancer Causes Control1991253073141932543
  • ShihSRChiuWYChangTCTsengCHDiabetes and thyroid cancer risk: literature reviewExp Diabetes Res2012201257828522778714
  • Bjerre KnudsenLMadsenLWAndersenSGlucagon-like Peptide-1 receptor agonists activate rodent thyroid C-cells causing calcitonin release and C-cell proliferationEndocrinology201015141473148620203154
  • LovshinJADruckerDJIncretin-based therapies for type 2 diabetes mellitusNat Rev Endocrinol20095526226919444259
  • SheltonJGSteelmanLSWhiteERMcCubreyJASynergy between PI3K/Akt and Raf/MEK/ERK pathways in IGF-1R mediated cell cycle progression and prevention of apoptosis in hematopoietic cellsCell Cycle20043337237914726697
  • FengCGaoYWangCAberrant overexpression of pyruvate kinase M2 is associated with aggressive tumor features and the BRAF mutation in papillary thyroid cancerJ Clin Endocrinol Metab2013989E1524E153323846818
  • KarlstadOStarup LindeJVestergaardPUse of insulin and insulin analogs and risk of cancer; systematic review and meta-analysis of observational studiesCurr Drug Saf20138533334824215311
  • HsiehMCLeeTCChengSMTuSTYenMHTsengCHThe influence of type 2 diabetes and glucose-lowering therapies on cancer risk in the TaiwaneseExp Diabetes Res2012201241378222719752
  • CarstensenBWitteDRFriisSCancer occurrence in Danish diabetic patients: duration and insulin effectsDiabetologia201155494895822120574
  • HabelLADanforthKNQuesenberryCPCohort study of insulin glargine and risk of breast, prostate, and colorectal cancer among patients with diabetesDiabetes Care201336123953396024170756
  • DrejerKThe bioactivity of insulin analogs from in vitro receptor binding to in vivo glucose uptakeDiabetes Metab Rev1992832592851338040
  • WeinsteinDSimonMYehezkelELaronZWernerHInsulin analogs display IGF-I-like mitogenic and anti-apoptotic activities in cultured cancer cellsDiabetes Metab Res Rev2009251414919145584
  • ShuklaAGrisouardJEhemannVHermaniAEnzmannHMayerDAnalysis of signaling pathways related to cell proliferation stimulated by insulin analogs in human mammary epithelial cell linesEndocr Relat Cancer200916242944119153208
  • SciaccaLLe MoliRVigneriRInsulin analogs and cancerFront Endocrinol (Lausanne)201232122649410
  • LiuYJQiangWShiJLvSQJiMJShiBYExpression and significance of IGF-1 and IGF-1R in thyroid nodulesEndocrine201344115816423288662
  • SchmidtJAAllenNEAlmquistMInsulin-like growth factor-I and risk of differentiated thyroid carcinoma in the European prospective investigation into cancer and nutritionCancer Epidemiol Biomarkers Prev201423697698524646451
  • RouseRXuLStewartSZhangJHigh fat diet and GLP-1 drugs induce pancreatic injury in miceToxicol Appl Pharmacol2014276210411424534256
  • ElashoffMMatveyenkoAVGierBElashoffRButlerPCPancreatitis, pancreatic, and thyroid cancer with glucagon-like peptide-1-based therapiesGastroenterology2011141115015621334333
  • ZhaoHWangLWeiRActivation of glucagon-like peptide-1 receptor inhibits tumourigenicity and metastasis of human pancreatic cancer cells via PI3K/Akt pathwayDiabetes Obes Metab201416985086024641303
  • GierBButlerPCLaiCKKirakossianDDeNicolaMMYehMWGlucagon like peptide-1 receptor expression in the human thyroid glandJ Clin Endocrinol Metab201297112113122031513
  • FangDHuangZGuanHThe Akt/FoxO1/p27 pathway mediates the proliferative action of liraglutide in beta cellsMol Med Rep20125123323821964769
  • WeiQSunYQZhangJExendin-4, a glucagon-like peptide-1 receptor agonist, inhibits cell apoptosis induced by lipotoxicity in pancreatic beta-cell linePeptides2012371182422776329
  • ChallaTDBeatonNArnoldMRudofskyGLanghansWWolfrumCRegulation of adipocyte formation by GLP-1/GLP-1R signalingJ Biol Chem201228796421643022207759
  • ChangWWLinRJYuJThe expression and significance of insulin-like growth factor-1 receptor and its pathway on breast cancer stem/progenitorsBreast Cancer Res2013153R3923663564
  • HanahanDWeinbergRAHallmarks of cancer: the next generationCell2011144564667421376230
  • LeeJSeolMYJeongSA metabolic phenotype based on mitochondrial ribosomal protein expression as a predictor of lymph node metastasis in papillary thyroid carcinomaMedicine (Baltimore)2015942e38025590838